Pseudomonal infections in patients with COPD: epidemiology and management.
about
Polymicrobial community-acquired pneumonia: An emerging entityPseudomonas aeruginosa disrupts Caenorhabditis elegans iron homeostasis, causing a hypoxic response and deathDetection of host-derived sphingosine by Pseudomonas aeruginosa is important for survival in the murine lungFitness of isogenic colony morphology variants of Pseudomonas aeruginosa in murine airway infectionThe development of ciprofloxacin resistance in Pseudomonas aeruginosa involves multiple response stages and multiple proteins.Bronchial microbiome of severe COPD patients colonised by Pseudomonas aeruginosaThe SENSOR Study: Protocol for a Mixed-Methods Study of Self-Management Checks to Predict Exacerbations of Pseudomonas Aeruginosa in Patients with Long-Term Respiratory Conditions.β1-Integrin Accumulates in Cystic Fibrosis Luminal Airway Epithelial Membranes and Decreases Sphingosine, Promoting Bacterial InfectionsAntipathogenic potential of marine Bacillus sp. SS4 on N-acyl-homoserine-lactone-mediated virulence factors production in Pseudomonas aeruginosa (PAO1).Mimicking the host and its microenvironment in vitro for studying mucosal infections by Pseudomonas aeruginosa.Broad-range potential of Asphodelus microcarpus leaves extract for drug developmentEfficacy and potential for resistance selection of antipseudomonal treatments in a mouse model of lung infection by hypermutable Pseudomonas aeruginosaMonomethylarsonous Acid (MMAIII) Has an Adverse Effect on the Innate Immune Response of Human Bronchial Epithelial Cells to Pseudomonas aeruginosaMycofabricated biosilver nanoparticles interrupt Pseudomonas aeruginosa quorum sensing systems.Epithelial expression of TLR4 is modulated in COPD and by steroids, salmeterol and cigarette smoke.Inhibition of quorum sensing-controlled virulence factor production in Pseudomonas aeruginosa by South Florida plant extracts.Ca2+ signaling in airway epithelial cells facilitates leukocyte recruitment and transepithelial migration.Identification of a hemin utilization protein of Moraxella catarrhalis (HumA).A conserved mitochondrial surveillance pathway is required for defense against Pseudomonas aeruginosa.β-Defensins: Work in Progress.Surfactant protein A blocks recognition of Pseudomonas aeruginosa by CKAP4/P63 on airway epithelial cells.Up-regulation of integrin expression in lung adenocarcinoma cells caused by bacterial infection: in vitro study.Effect of dexamethasone and ACC on bacteria-induced mucin expression in human airway mucosa.A novel mouse model of conditional IRAK-M deficiency in myeloid cells: application in lung Pseudomonas aeruginosa infection.Pseudomonas aeruginosa adaptation in the nasopharyngeal reservoir leads to migration and persistence in the lungs.Hypermutation is a key factor in development of multiple-antimicrobial resistance in Pseudomonas aeruginosa strains causing chronic lung infectionsEffectiveness of treatment with nebulized colistin in patients with COPDChronic respiratory infections by mucoid carbapenemase-producing Pseudomonas aeruginosa strains, a new potential public health problem.N-(3-oxo-acyl)homoserine lactones signal cell activation through a mechanism distinct from the canonical pathogen-associated molecular pattern recognition receptor pathways.Bacteriology in acute exacerbation of chronic obstructive pulmonary disease in patients admitted to hospital.Effect of aerosolized colistin on multidrug-resistant Pseudomonas aeruginosa in bronchial secretions of patients without cystic fibrosis.Syk inhibitor R406 downregulates inflammation in an in vitro model of Pseudomonas aeruginosa infection.The effect of burdock leaf fraction on adhesion, biofilm formation, quorum sensing and virulence factors of Pseudomonas aeruginosa.
P2860
Q26780356-30F819DE-88F7-48AD-9A9B-0FDA98588049Q28289283-92908C1D-029D-4828-BE07-2E9894E2B59DQ28492560-233CA446-1865-4F11-820C-EA9AE5A579B1Q33321247-31C6F35C-DE68-4D98-8B39-94B25BC90D9CQ33653162-49856147-E67E-4525-B74C-855C9D7B2F87Q33701145-A5B0B710-6D39-4D12-AD5F-51C95FE3639DQ33759200-CB0A64D8-788D-4EFD-B404-55E68F27FCF5Q33811046-E6EF34BA-947B-480C-AA9F-4CF10EDC0547Q33858007-EDFE2ADF-CBF9-455B-9E73-A1A30639FF5DQ33897664-3FF77304-8425-4521-8740-B94D700D17C1Q33909661-50BC8C79-1CEF-4D40-8857-75EC96360D25Q34509793-7EE924FA-64D3-46B6-9E64-E3C5E9448A35Q35837070-1D6B9C49-821B-479C-9451-5FC7106355B8Q36035209-4069EA72-1EF6-450B-A750-31A0BC8D6DEDQ36372827-A028EEE5-9640-4E29-BDD7-E6DF3844906EQ36422600-428F18FC-EBB3-4916-91FE-7F1A385B1985Q37552431-C5574A79-938C-44D2-832A-53F8A1B71E7FQ37582884-201E2FA6-F877-4E9E-91D2-6D6069C4C10AQ38702405-AB0BE093-8AF2-45DC-BFBF-9284BE4A50B2Q38728628-27142B1C-0C9B-4DAA-A7FF-B9CC1217BBABQ39281402-5CE2F60F-91C3-4E63-A0C4-7BA2D3B16A06Q39807837-7A22570E-1321-44D8-AEE9-6DD415DC301DQ40113796-A68B89F5-438A-411D-9A1D-D38A92532A46Q40359112-0EB5A883-16EF-4849-94C0-FFF2E3922C28Q41758615-F3294E20-601F-4517-947F-353FC9B0CC02Q41974061-8A9C0E5A-0A9D-4DDB-8E16-FD6C4E71FE77Q42373825-73C74D75-E3C8-480C-9DC1-AF16F6076D77Q43253659-B6D264A3-A143-41C0-8583-86F099243310Q43910356-A07125B2-830C-436D-903F-A32E5CF1C8B6Q44436155-9C1C26D4-098E-44D4-8876-2B7EA9994CBCQ45159730-5B341735-E03E-45C3-8743-6843729C5242Q47666753-ACF41495-A6BB-4BE5-AD43-2E9B9BC93039Q47850505-A36DAF42-821A-40A5-B800-DFAD0667D106
P2860
Pseudomonal infections in patients with COPD: epidemiology and management.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Pseudomonal infections in patients with COPD: epidemiology and management.
@ast
Pseudomonal infections in patients with COPD: epidemiology and management.
@en
type
label
Pseudomonal infections in patients with COPD: epidemiology and management.
@ast
Pseudomonal infections in patients with COPD: epidemiology and management.
@en
prefLabel
Pseudomonal infections in patients with COPD: epidemiology and management.
@ast
Pseudomonal infections in patients with COPD: epidemiology and management.
@en
P2860
P356
P1476
Pseudomonal infections in patients with COPD: epidemiology and management.
@en
P2093
David Lieberman
Devora Lieberman
P2860
P2888
P304
P356
10.1007/BF03256673
P577
2003-01-01T00:00:00Z